Download FDA Orange Book Archives
How to Order the FDA Orange Book Historical copies of the FDA Orange Book archives are very potent tools for […]
Insights
Value-Based Drug Pricing: A Promising Yet Challenging Approach to Healthcare Reform
In the complex world of healthcare economics, few topics generate as much debate and interest as drug pricing. As healthcare
Value-Based Drug Pricing: A Promising Yet Challenging Approach to Healthcare Reform Read Post »
The Cost Of A Cure: Patent Rights And Drug Prices
The Pharmaceutical Landscape: A Delicate Balance In the complex world of healthcare, few topics spark as much debate as the
The Cost Of A Cure: Patent Rights And Drug Prices Read Post »
How a $37,000-a-year medicine sets a good model for drug pricing
In the complex and often controversial world of pharmaceutical pricing, a $37,000-a-year medicine is emerging as an unexpected model for
How a $37,000-a-year medicine sets a good model for drug pricing Read Post »
3 big mistakes drug companies make in recruiting new employees
Three Big Mistakes Drug Companies Make in Recruiting New Employees In the fast-paced world of biopharmaceuticals, recruiting top talent is
3 big mistakes drug companies make in recruiting new employees Read Post »
As blockbuster drugs fizzle, biotech looks warily to the next big thing
The biopharmaceutical industry stands at a crossroads. The era of blockbuster drugs, once the lifeblood of big pharma, is waning.
As blockbuster drugs fizzle, biotech looks warily to the next big thing Read Post »
Americans overspend $73bn on branded drugs
File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food
Mark Cuban Sounds Off on Drug Prices
By Dylan Scott, Posted with permission from STAT Mark Cuban has something to say about prescription drug prices. The billionaire
Some biosimilars are just as good as some pricey biologics
Some Biosimilars Are Just as Good as Some Pricey Biologics: A Game-Changer in Healthcare In the world of medicine, we’re
Some biosimilars are just as good as some pricey biologics Read Post »